Peak Retirement Planning Inc. Invests $1.03 Million in Option Care Health, Inc. (NASDAQ:OPCH)

Peak Retirement Planning Inc. acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 40,103 shares of the company's stock, valued at approximately $1,026,000.

Several other large investors have also modified their holdings of the stock. Public Employees Retirement System of Ohio lifted its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares during the period. Cornerstone Investment Partners LLC raised its holdings in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after buying an additional 333 shares during the period. UMB Bank n.a. raised its holdings in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the period. Assetmark Inc. raised its holdings in Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after buying an additional 487 shares during the period. Finally, Pacer Advisors Inc. raised its holdings in Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after buying an additional 537 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.64% of the company's stock.

Option Care Health Stock Down 1.2%

NASDAQ:OPCH traded down $0.38 during trading hours on Wednesday, hitting $31.74. The stock had a trading volume of 881,761 shares, compared to its average volume of 1,854,898. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The business has a 50 day simple moving average of $32.89 and a two-hundred day simple moving average of $29.47. The company has a market cap of $5.20 billion, a PE ratio of 26.67, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter last year, the company earned $0.26 earnings per share. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. Analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently commented on OPCH. JMP Securities restated a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. raised their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.